DOI:
10.1055/s-00030576
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics
LinksClose Window
References
Cortés-Charry R, Hennah L, Froeling FEM, Short D, Aguiar X, Tin T. et al.
Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy.
ESMO Open 2021;
6 (03) 100110
DOI: 10.1016/j.esmoop.2021.100110.
We do not assume any responsibility for the contents of the web pages of other providers.